Trinity Biotech (TRIB) SEC Filings & 10K Form

$1.83
0.00 (0.00%)
(As of 04/25/2024 ET)

Recent Trinity Biotech SEC Filings

DateFilerForm TypeView
04/05/2024
12:05 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/15/2024
1:11 PM
Trinity Biotech (Filer)
Form 424B3
02/09/2024
6:51 PM
PERCEPTIVE ADVISORS LLC (Filed by)
Trinity Biotech (Subject)
Form SC 13D
02/01/2024
10:33 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/01/2024
10:37 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/02/2024
3:17 PM
MiCo IVD Holdings, LLC (Filed by)
Trinity Biotech (Subject)
Form SC 13D/A
01/02/2024
3:13 PM
MiCo Co., Ltd. (Filed by)
Trinity Biotech (Subject)
Form SC 13D/A
01/02/2024
1:02 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/19/2023
12:56 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/29/2023
8:00 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/06/2023
3:05 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/12/2023
3:04 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/05/2023
2:38 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/10/2023
5:02 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/16/2023
1:54 PM
Trinity Biotech (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
05/08/2023
8:04 AM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/01/2023
3:15 PM
Trinity Biotech (Filer)
Form NT 20-F
05/01/2023
12:43 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/25/2023
3:40 PM
Trinity Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:TRIB) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners